Physician Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of PESI Inc. and Diabetes Technology Society (DTS). PESI Inc. is accredited by the ACCME to provide continuing medical education for physicians.
AMA PRA Designation Statement
PESI, Inc. designates this Internet live educational activity for a maximum of 11 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
International Physicians are formally eligible for AMA PRA Category 1 Credit™.
AAPA accepts Category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA PRA Category 1 Credit™ for the PRA from organizations accredited by ACCME.
For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME (Accreditation Council for Continuing Medical Education) for attendance at structured learning activities.
Aspen CME Services is approved by the California Board of Registered Nursing, Provider number CEP14739, for 11 contact hours.
For the purpose of recertification, the American Council of Pharmacy Education accepts AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME (Accreditation Council for Continuing Medical Education) for attendance at structured learning activities.
The National Certification Board for Diabetes Educators recognizes courses sponsored by PESI Inc. as approved ACCME provider. This course qualifies for 11 continuing education hours.
*Accreditation is for specific general sessions only. Pre- Meeting workshops are not accredited.
Satisfactory Completion for credits:
All attendees must have completed a course attendance/evaluation form immediately following the conference. Each session claimed for credit must be attended in it’s entirely.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. PESI Inc., Aspen CME Services and Diabetes Technology Society do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with the activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindication, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in the activity should not be used by clinicians without evaluation of patient condition and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.